Real-World Evidence (RWE) Studies

Harness Disease-Specific Data to Drive Meaningful Clinical Insights and Research

At Verana Health, we unlock the power of longitudinal real-world data (RWD) from leading specialty medical societies — the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) and the American Urological Association (AUA) Quality (AQUA)® Registry  — to drive insights for real-world evidence (RWE) studies.

Our comprehensive real-world datasets, called Qdata®, contain research-ready variables curated from both structured and unstructured fields from EHRs. Qdata datasets enable life sciences companies to generate robust evidence across a spectrum of clinical research needs.

Our RWE Studies solutions, powered by Qdata in ophthalmology, urology, and neurology, offer deep, meaningful insights into patient populations, treatment patterns, and outcomes. This allows life sciences companies to make informed decisions, improve patient care, and support payer, regulatory, and market access strategies with real-world clinical data.

Meet with Verana Health

Comprehensive RWE Studies Solutions for Life Sciences

Each of the following RWE solutions offers a unique lens on real-world clinical evidence derived from RWD within the IRIS Registry and AQUA Registry. These solutions address the following key research and clinical objectives:

Treatment Patterns and Outcomes

Identify and analyze how patients are treated and their associated outcomes in real-world settings. Understand treatment patterns, switching, and discontinuation trends, along with the outcomes they produce. This real-world evidence studies solution offers insights that are essential for optimizing therapeutic strategies and improving patient outcomes. Learn more about Treatment Patterns and Outcomes.

Comparative Effectiveness

Compare the performance of various treatments among real-world patient populations. This solution enables the evaluation of the effectiveness of different therapies and procedures, providing valuable evidence to support market differentiation and clinician messaging. Learn more about Comparative Effectiveness

Natural History of Disease / Disease Progression

Gain insights into the natural history of diseases in the real world. This solution tracks patients longitudinally to assess how diseases present and progress in real-world patients and can help increase disease awareness and diagnosis rates, understand disease burden, and inform long-term patient management strategies. Learn more about Natural History of Disease / Disease Progression.

Safety Studies

Evaluate the safety and tolerability of treatments in real-world patients. With this RWE studies solution, researchers can assess rare adverse events that may not have been identified during clinical trials, identify at-risk populations, and provide postmarketing safety data that regulators and clinicians rely on for informed decision-making. Learn more about Safety Studies.

Patient Segmentation

Uncover and categorize distinct patient subgroups based on patient demographic and clinical characteristics, as well as outcomes data not found in claims data. This segmentation enables the identification of potential high- or poor-responders and can help tailor treatment approaches to maximize patient outcomes. Learn more about Patient Segmentation.

Healthcare Resource Utilization (HCRU)

Examine the real-world costs associated with treatments and healthcare resource use. This real-world evidence solution provides critical insights into the economic burden of diseases and treatments, supporting value-based care initiatives and health economic models. Learn more about Healthcare Research Utilization.

Meet with Verana Health

Why Choose Verana Health for RWE Studies?

Our trusted data-driven approach to RWE sets us apart by ensuring that each dataset is meticulously curated to reflect real-world clinical interactions. With Verana Health, you can trust that our Qdata provides:

High-quality insights: Our exclusive access to de-identified, longitudinal data from the IRIS Registry and AQUA Registry ensures comprehensive coverage of ophthalmology and urology patient journeys.

Regulatory-grade evidence: Qdata has been used to support submissions to regulatory bodies, giving you the confidence that our data meets the highest standards of evidence generation. Read a related article.

Advanced analytics: Powered by cutting-edge technology, our RWE solutions deliver actionable insights to help you understand clinical and economic outcomes, optimize market access, and guide future research.

Featured Content

Press

Verana Health Launches Urology Qdata Insights Offerings at American Urological Association Annual Meeting

May 2022
→
Press

Verana Health Launches Qdata® Glaucoma to Deliver Real-World Insights into Glaucoma Patient Journey

March 2022
→
Blog

Verana Health: Accelerating Healthcare Innovation with Real World Evidence

February 2020
→
VeranaHealth_Logo

Contact us to learn more about real-world evidence solutions.